Nadeem R. Abu‐Rustum

Author

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

M.J. Eijkemans, N ABURUSTUM, N Abu-Rustum, N R Abu-Rustum, N R. Abu-Rustum, N. Abu-Rustum, N. R. Abu-Rustum, N.R. ABU-RUSTUM, N.R. Abu-Rustum, NADEEM R. ABU-RUSTUM

836

Publications

33.1K

Citations

H-Index

168

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University The University of Texas MD Anderson Cancer Center Massachusetts General Hospital

About

Nadeem R. Abu‐Rustum is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	74	240	20.7K
2	Public Health	26	38	4.3K
3	Health Sciences	19	23	2.2K
4	Engineering	3	3	169
5	Nursing	1	1	35

Nadeem R. Abu‐Rustum

347

Publications

28.6K

Citations

H-Index

Page 1

	Year	Citations
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA M.C. Liu, Geoffrey R. Oxnard, Eric A. Klein, Annals of Oncology	2020	1.4K
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology Wui-Jin Koh, Nadeem R. Abu‐Rustum, Sarah M. Bean, Journal of the National Comprehensive Cancer Network Precancerous LesionsCancer ManagementGynecologyPathologyGynecology Oncology	2019	1K
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology Wui-Jin Koh, Nadeem R. Abu‐Rustum, Sarah Bean, Journal of the National Comprehensive Cancer Network Surgical OncologyTumoral PathologyGynecological SurgeryMalignant DiseaseEndocrine-related Cancer	2018	642
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? D.S. Chi, Eric Eisenhauer, J. Lang, Gynecologic Oncology Gynecologic SurgerySurgical OncologyPrimary Cytoreductive SurgeryGynecological SurgeryMedicine	2006	624
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Cell UrologyTumor HeterogeneityMedicineNext-generation SequencingPathology	2022	608
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm S. Dennis, Eric Eisenhauer, Oliver Zivanovic, Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgerySurgical ParadigmAdvanced Ovarian Cancer	2009	581
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementGynecologyPathologyGynecology Oncology	2023	506
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: Beyond removal of blue nodes Joyce N. Barlin, Fady Khoury‐Collado, Christine H. Kim, Gynecologic Oncology Endometrial Cancer StagingGynecological SurgeryMedical ImagingSentinel Lymph NodeMedicine	2012	396
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinoma S. Dennis, Kristina McCaughty, John P. Diaz, Cancer	2006	355
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020 Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Sarah Bean, Journal of the National Comprehensive Cancer Network Cancer ManagementNccn Guidelines InsightsGynecologyPathologyCytopathology	2020	353

Page 1